Payment overview · 2025
General Payments
$18.24
1 reported records · 1 companies
Healthcare provider profile · identity verified
Timothy John Dalton, MD
Allopathic & Osteopathic Physicians|Internal Medicine · WINSTON-SALEM, NC · NPI 1912900648
Verified facts
What the public records show
CMS Open Payments records show Timothy John Dalton, MD received $18.24 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.24 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.24 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $18.24 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 924 | 251 |
| Atorvastatin Calcium | Atorvastatin Calcium | 730 | 215 |
| Lisinopril | Lisinopril | 593 | 176 |
| Hydrochlorothiazide | Hydrochlorothiazide | 471 | 125 |
| Gabapentin | Gabapentin | 439 | 100 |
| Metformin Hcl | Metformin Hcl | 395 | 119 |
| Metoprolol Succinate | Metoprolol Succinate | 369 | 111 |
| Levothyroxine Sodium | Levothyroxine Sodium | 311 | 79 |
| Omeprazole | Omeprazole | 294 | 79 |
| Sertraline Hcl | Sertraline Hcl | 280 | 58 |
| Losartan Potassium | Losartan Potassium | 259 | 68 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 231 | 78 |
| Tamsulosin Hcl | Tamsulosin Hcl | 230 | 73 |
| Simvastatin | Simvastatin | 226 | 67 |
| Trazodone Hcl | Trazodone Hcl | 222 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 219 | 58 |
| Alprazolam | Alprazolam | 216 | 45 |
| Baclofen | Baclofen | 207 | 68 |
| Furosemide | Furosemide | 202 | 57 |
| Eliquis | Apixaban | 191 | 38 |
| Atenolol | Atenolol | 188 | 45 |
| Zolpidem Tartrate | Zolpidem Tartrate | 173 | 26 |
| Celecoxib | Celecoxib | 156 | 43 |
| Alendronate Sodium | Alendronate Sodium | 154 | 41 |
| Tramadol Hcl | Tramadol Hcl | 149 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 147 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 140 | 37 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 140 | 32 |
| Carvedilol | Carvedilol | 135 | 35 |
| Lamotrigine | Lamotrigine | 134 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 132 | 36 |
| Jardiance | Empagliflozin | 117 | 24 |
| Glipizide | Glipizide | 112 | 28 |
| Potassium Chloride | Potassium Chloride | 110 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 107 | 35 |
| Mirtazapine | Mirtazapine | 105 | 23 |
| Famotidine | Famotidine | 104 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 100 | 25 |
| Clonazepam | Clonazepam | 100 | 18 |
| Irbesartan | Irbesartan | 97 | 28 |
| Dicyclomine Hcl | Dicyclomine Hcl | 92 | 24 |
| Allopurinol | Allopurinol | 91 | 25 |
| Bupropion Xl | Bupropion Hcl | 90 | 25 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 90 | 25 |
| Prednisone | Prednisone | 90 | 58 |
| Montelukast Sodium | Montelukast Sodium | 89 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 88 | 26 |
| Meloxicam | Meloxicam | 83 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 81 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 78 | 20 |
| Topiramate | Topiramate | 77 | 19 |
| Clonidine Hcl | Clonidine Hcl | 75 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 75 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 73 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 73 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 71 | 25 |
| Ozempic | Semaglutide | 69 | 14 |
| Lorazepam | Lorazepam | 67 | 14 |
| Diazepam | Diazepam | 65 | 14 |
| Januvia | Sitagliptin Phosphate | 61 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 60 | 18 |
| Temazepam | Temazepam | 58 | 11 |
| Meclizine Hcl | Meclizine Hcl | 57 | 18 |
| Metformin Hcl Er | Metformin Hcl | 56 | 20 |
| Pregabalin | Pregabalin | 56 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 54 | 15 |
| Buspirone Hcl | Buspirone Hcl | 53 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 43 |
| Enalapril Maleate | Enalapril Maleate | 52 | 12 |
| Glipizide Er | Glipizide | 51 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 50 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 48 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 46 | 44 |
| Finasteride | Finasteride | 44 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 44 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 15 |
| Promethazine Hcl | Promethazine Hcl | 42 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 11 |
| Methotrexate | Methotrexate Sodium | 41 | suppressed |
| Glimepiride | Glimepiride | 40 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 36 |
| Estradiol | Estradiol | 39 | suppressed |
| Xarelto | Rivaroxaban | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | 12 |
| Primidone | Primidone | 37 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Risperidone | Risperidone | 33 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 33 | 12 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 31 | suppressed |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | 11 |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Febuxostat | Febuxostat | 26 | suppressed |
| Ramipril | Ramipril | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Carisoprodol | Carisoprodol | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 24 | suppressed |
| Naproxen | Naproxen | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Ezetimibe | Ezetimibe | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Invokana | Canagliflozin | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | 11 |
| Linzess | Linaclotide | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Synthroid | Levothyroxine Sodium | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Cephalexin | Cephalexin | 15 | 14 |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Buprenorphine | Buprenorphine | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 11 |
| Klor-Con M10 | Potassium Chloride | 13 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Vaqta | Hepatitis A Virus Vaccine/Pf | 13 | suppressed |
| Aliskiren | Aliskiren Hemifumarate | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Cimetidine | Cimetidine | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Restasis Multidose | Cyclosporine | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.24 · 1 records | Amgen Inc. | KRYSTEXXA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error